Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Indinavir

🥰Excellent
Catalog No. T5863LCas No. 150378-17-9
Alias MK639 free base

Indinavir is an orally administered, specific HIV protease inhibitor commonly used in combination therapy as part of highly active antiretroviral therapy (HAART) for HIV/AIDS. Indinavir also inhibits the activation of MMP-2 in endothelial cells and exhibits affinity for α7-nAchR and SARS-CoV-2 Mpro.

Indinavir

Indinavir

🥰Excellent
Catalog No. T5863LAlias MK639 free baseCas No. 150378-17-9
Indinavir is an orally administered, specific HIV protease inhibitor commonly used in combination therapy as part of highly active antiretroviral therapy (HAART) for HIV/AIDS. Indinavir also inhibits the activation of MMP-2 in endothelial cells and exhibits affinity for α7-nAchR and SARS-CoV-2 Mpro.
Pack SizePriceAvailabilityQuantity
1 mg$67In Stock
5 mg$162In Stock
Add to Cart
Add to Quotation
Bulk & Custom
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
View More

Batch Information

Select Batch
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Indinavir is an orally administered, specific HIV protease inhibitor commonly used in combination therapy as part of highly active antiretroviral therapy (HAART) for HIV/AIDS. Indinavir also inhibits the activation of MMP-2 in endothelial cells and exhibits affinity for α7-nAchR and SARS-CoV-2 Mpro.
In vitro
Method:
Peripheral blood mononuclear cells (PBMCs) from healthy and HIV-infected individuals were pretreated with Indinavir at concentrations ranging from 0 to 50 μM for 18 hours, followed by stimulation with anti-CD3 antibody for an additional 48 hours.

Result:
Indinavir inhibited anti-CD3-induced cell cycle progression in a dose-dependent manner and reduced lymphoproliferative responses in a dose-dependent fashion. [1]
In vivo
Method:
Huh7 and SK-HEP-1 hepatocarcinoma cells were subcutaneously implanted into nude mice. After tumor establishment, Indinavir was administered by oral gavage at a dose of 70 mg/kg once daily for 3 weeks.

Result:
Compared with the control group, Indinavir delayed the growth of subcutaneously implanted hepatocarcinoma xenografts in nude mice.[2]
SynonymsMK639 free base
Chemical Properties
Molecular Weight613.79
FormulaC36H47N5O4
Cas No.150378-17-9
SmilesN(C([C@H](CC1=CC=CC=C1)C[C@@H](CN2[C@H](C(NC(C)(C)C)=O)CN(CC=3C=CC=NC3)CC2)O)=O)[C@H]4C=5C(C[C@H]4O)=CC=CC5
Relative Density.1.25 g/cm3
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (130.34 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.6292 mL8.1461 mL16.2922 mL81.4611 mL
5 mM0.3258 mL1.6292 mL3.2584 mL16.2922 mL
10 mM0.1629 mL0.8146 mL1.6292 mL8.1461 mL
20 mM0.0815 mL0.4073 mL0.8146 mL4.0731 mL
50 mM0.0326 mL0.1629 mL0.3258 mL1.6292 mL
100 mM0.0163 mL0.0815 mL0.1629 mL0.8146 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Sci Citations

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Indinavir | purchase Indinavir | Indinavir cost | order Indinavir | Indinavir chemical structure | Indinavir in vivo | Indinavir in vitro | Indinavir formula | Indinavir molecular weight